Fusion Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $574K | Sell |
3,094
-10
| -0.3% | -$1.86K | 0.2% | 50 |
|
|
2025
Q1 | $650K | Sell |
3,104
-273
| -8% | -$57.2K | 0.25% | 45 |
|
|
2024
Q4 | $600K | Buy |
3,377
+23
| +0.7% | +$4.09K | 0.24% | 51 |
|
|
2024
Q3 | $662K | Buy |
3,354
+21
| +0.6% | +$4.15K | 0.28% | 42 |
|
|
2024
Q2 | $572K | Sell |
3,333
-90
| -3% | -$15.4K | 0.26% | 42 |
|
|
2024
Q1 | $623K | Sell |
3,423
-36
| -1% | -$6.56K | 0.29% | 41 |
|
|
2023
Q4 | $536K | Sell |
3,459
-274
| -7% | -$42.5K | 0.27% | 38 |
|
|
2023
Q3 | $556K | Sell |
3,733
-102
| -3% | -$15.2K | 0.31% | 36 |
|
|
2023
Q2 | $517K | Buy |
3,835
+85
| +2% | +$11.5K | 0.29% | 37 |
|
|
2023
Q1 | $598K | Buy |
3,750
+31
| +0.8% | +$4.94K | 0.34% | 33 |
|
|
2022
Q4 | $601K | Buy |
3,719
+154
| +4% | +$24.9K | 0.35% | 35 |
|
|
2022
Q3 | $479K | Sell |
3,565
-49
| -1% | -$6.58K | 0.31% | 37 |
|
|
2022
Q2 | $554K | Sell |
3,614
-12
| -0.3% | -$1.84K | 0.34% | 36 |
|
|
2022
Q1 | $588K | Buy |
3,626
+34
| +0.9% | +$5.51K | 0.31% | 39 |
|
|
2021
Q4 | $486K | Buy |
3,592
+200
| +6% | +$27.1K | 0.25% | 46 |
|
|
2021
Q3 | $366K | Buy |
3,392
+215
| +7% | +$23.2K | 0.22% | 54 |
|
|
2021
Q2 | $358K | Buy |
3,177
+96
| +3% | +$10.8K | 0.22% | 53 |
|
|
2021
Q1 | $333K | Buy |
3,081
+113
| +4% | +$12.2K | 0.22% | 53 |
|
|
2020
Q4 | $318K | Buy |
2,968
+138
| +5% | +$14.8K | 0.23% | 52 |
|
|
2020
Q3 | $248K | Buy |
2,830
+81
| +3% | +$7.1K | 0.22% | 55 |
|
|
2020
Q2 | $270K | Buy |
+2,749
| New | +$270K | 0.26% | 48 |
|